ClinicalTrials.Veeva

Menu

Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease

S

Sohag University

Status

Enrolling

Conditions

Behçet

Study type

Observational

Funder types

Other

Identifiers

NCT06721234
Soh-Med--24-11-03MS

Details and patient eligibility

About

Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations

Enrollment

100 estimated patients

Sex

All

Ages

19 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients fulfill the International Criteria for Behcet's Disease (ICBD)
  • Age above 18 years old
  • Patients cooperative and can answer questions
  • Patients who are able and willing to give informed consent

Exclusion criteria

  • Other rheumatological and vascular diseases
  • Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
  • Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
  • Patients who are using aspirin and other platelet active drygs during the previous 6 months
  • patients who are not able and willing to give written consent

Trial contacts and locations

1

Loading...

Central trial contact

Engy L Fawzy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems